BamSEC and AlphaSense Join Forces
Learn More

ELOXX PHARMAC.NEW DL-01

OTC: 3970:BE    
Share price (10/14/24): $6.40    
Market cap (10/14/24): $20.1 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 10 pages ELOXX Pharmaceuticals, Inc. Amendment to Stock Option Agreement
12/34/56
EX-10.1
from S-3 36 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 10-Q 14 pages Eloxx Pharmaceuticals, Inc. Stock Option Grant Notice
12/34/56
EX-10.2
from 10-Q 13 pages Eloxx Pharmaceuticals, Inc. Restricted Stock Unit Grant Notice
12/34/56
EX-10.1
from 10-Q 59 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 91 pages Agreement
12/34/56
EX-10.1
from 8-K 10 pages Agreement and General Release
12/34/56
EX-10.5
from 10-Q 8 pages First Amendment to Lease
12/34/56
EX-10.4
from 10-Q 44 pages Lease Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Employment Offer Letter
12/34/56
EX-10.3
from 8-K 9 pages Separation Agreement and General Release
12/34/56
EX-10.2
from 8-K 18 pages 1. Employment Term. the Company Hereby Offers to Employ the Executive, and the Executive Hereby Accepts Employment by the Company, Upon the Terms and Conditions Set Forth in This Agreement, During the Period Commencing on the Effective Date and Ending on the Date of the Termination of the Executive’s Employment in Accordance With Section 7 Below (The “Employment Term”). the Executive Shall Be Employed at Will, Meaning That Either the Company or the Executive May Terminate This Agreement and the Executive’s Employment at Any Time, for Any Reason or No Reason, With or Without Cause, Subject to the Terms of This Agreement. 2. Position & Duties
12/34/56
EX-10.1
from 8-K 18 pages Executive Employment Agreement
12/34/56
EX-10.44
from 10-K 2 pages Employment Offer Letter
12/34/56
EX-10.43
from 10-K 18 pages Executive Employment Agreement
12/34/56
EX-10.42
from 10-K 18 pages Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 19 pages Eloxx Pharmaceuticals, Inc. Change in Control Severance Benefit Plan Approved by the Board of Directors: September 17, 2019
12/34/56
EX-10.38
from 10-K 12 pages 2. Position & Duties
12/34/56
EX-10.1
from 8-K 38 pages Eloxx Pharmaceuticals, Inc. $50,000,000 Shares of Common Stock ($0.01 Par Value) Equity Distribution Agreement
12/34/56
EX-10.6
from 10-Q 11 pages Eloxx Pharmaceuticals, Inc. Restricted Stock Unit Grant Notice
12/34/56